BIOREM Inc.
BRM.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.29% | 11.51% | -15.79% | 21.38% | 26.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.29% | 11.51% | -15.79% | 21.38% | 26.84% |
| Cost of Revenue | 16.73% | 6.61% | -6.34% | 27.44% | 36.23% |
| Gross Profit | 38.16% | 24.79% | -35.93% | 7.47% | 6.02% |
| SG&A Expenses | 16.17% | 7.45% | -8.75% | 25.91% | 26.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00% | 100.00% | -1,616.67% | -- | -- |
| Total Operating Expenses | 17.00% | 7.10% | -7.02% | 26.68% | 33.96% |
| Operating Income | 64.29% | 43.61% | -56.66% | -7.13% | -10.79% |
| Income Before Tax | 72.76% | 49.89% | -58.90% | -7.81% | -7.57% |
| Income Tax Expenses | 55.45% | 34.83% | -55.41% | 3.80% | 6.02% |
| Earnings from Continuing Operations | 79.06% | 55.35% | -60.05% | -11.41% | -11.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.06% | 55.35% | -60.05% | -11.41% | -11.69% |
| EBIT | 64.29% | 43.61% | -56.66% | -7.13% | -10.79% |
| EBITDA | 56.70% | 40.98% | -52.82% | -1.28% | -4.62% |
| EPS Basic | 84.32% | 59.96% | -60.59% | -12.04% | -11.94% |
| Normalized Basic EPS | 77.45% | 54.06% | -59.48% | -8.46% | -7.76% |
| EPS Diluted | 96.38% | 69.69% | -62.26% | -17.26% | -18.02% |
| Normalized Diluted EPS | 84.06% | 59.43% | -60.71% | -14.66% | -14.79% |
| Average Basic Shares Outstanding | -0.40% | 0.40% | 1.48% | 1.32% | 0.79% |
| Average Diluted Shares Outstanding | -3.23% | -2.24% | 3.59% | 5.27% | 9.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |